论文部分内容阅读
心肌梗塞是心血管疾病死亡的首要原因,对心梗的防治具有重要意义。天津中医学院研制的中药复方心复康在临床治疗冠心病获得确切疗效的同时发现具有明显降低心肌梗塞发病率的作用。该课题组对该药对实验性心肌梗塞大鼠心肌细胞能量代谢的改善、血清心肌酶活性的影响及体外培养心肌细胞酶活性及其脂质过氧化反应的影响等进行实验研究。现将其有关研究成果专题报道如下。
Myocardial infarction is the leading cause of death from cardiovascular disease and has important implications for the prevention and treatment of myocardial infarction. The traditional Chinese medicine compound Xinfukang, developed by Tianjin University of Traditional Chinese Medicine, has been found to have a significant effect in reducing the incidence of myocardial infarction. The experimental group investigated the effect of the drug on the improvement of myocardial cell energy metabolism, serum myocardial enzyme activity and the effect of in vitro cultured myocardial cell enzyme activity and lipid peroxidation on experimental myocardial infarction rats. The special reports on its research results are as follows.